Back to search
Agitation Associated With Bipolar Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Agitation Associated With Bipolar Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Agitation Associated With Bipolar Disorder trials you may qualify forThis open-label study will utilize treatment with BXCL501 in order to assess the suitability of patient-and lay informant-assessed outcome measures for evaluati…
This postmarketing observational study will evaluate the safety of ADASUVE® in treating patients with agitation associated with schizophrenia or bipolar I disor…
In this study, an investigational medication named BXCL501 is being tested for the treatment of episodes of agitation associated with bipolar I and bipolar II d…